Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A De Man

Showing results (51-60 of 543) with videos related to

Pageof 55
Sort By:
Gut|August 23, 2008
Somatostatin analogues reduce liver volume in polycystic liver diseaseL van Keimpema, R A de Man, J P H Drenth
Journal of Cardiovascular Pharmacology|January 1, 1990
Determinants of blood pressure in the first decades of lifeD E Grobbee, I M van Hooft, S A de Man
Journal of Hepatology|January 2, 2016
Reply to "Surveillance for hepatocellular carcinoma: A tale of two countries"Suzanne van Meer, Robert A de Man, Karel J van Erpecum
Journal of Hepatology|October 9, 1998
Clinical impact of lamivudine resistance in chronic hepatitis BP Honkoop, R A de Man, H G Niesters, et al.
Nederlands Tijdschrift Voor Geneeskunde|March 20, 1993
[Nocardiosis: a treacherous generalized infection]R A de Man, C Hilvering, H J Groen, et al.
The Netherlands Journal of Medicine|February 3, 2005
A randomised study on the efficacy and safety of an automated Tru-Cut needle for percutaneous liver biopsyR A de Man, H R van Buuren, W C J Hop
Liver|April 1, 1997
Histological improvement in patients with chronic hepatitis B virus infection treated with lamivudineP Honkoop, R A de Man, P E Zondervan, et al.
Journal of Hepatology|June 13, 1998
Efficacy of famciclovir treatment in chronic hepatitis B patients with different mutations at position 552 of the DNA polymerase geneL M Wolters, P Honkoop, H G Niesters, et al.
Drug Safety|July 1, 1997
Mitochondrial injury. Lessons from the fialuridine trialP Honkoop, H R Scholte, R A de Man, et al.
Lancet (London, England)|October 28, 1995
Hepatitis B reactivation after lamivudineP Honkoop, R A de Man, R A Heijtink, et al.
Pageof 55

Showing results (51-60 of 543) with videos related to

Sort By:
Pageof 55
Gut|August 23, 2008
Somatostatin analogues reduce liver volume in polycystic liver diseaseL van Keimpema, R A de Man, J P H Drenth
Journal of Cardiovascular Pharmacology|January 1, 1990
Determinants of blood pressure in the first decades of lifeD E Grobbee, I M van Hooft, S A de Man
Journal of Hepatology|January 2, 2016
Reply to "Surveillance for hepatocellular carcinoma: A tale of two countries"Suzanne van Meer, Robert A de Man, Karel J van Erpecum
Journal of Hepatology|October 9, 1998
Clinical impact of lamivudine resistance in chronic hepatitis BP Honkoop, R A de Man, H G Niesters, et al.
Nederlands Tijdschrift Voor Geneeskunde|March 20, 1993
[Nocardiosis: a treacherous generalized infection]R A de Man, C Hilvering, H J Groen, et al.
The Netherlands Journal of Medicine|February 3, 2005
A randomised study on the efficacy and safety of an automated Tru-Cut needle for percutaneous liver biopsyR A de Man, H R van Buuren, W C J Hop
Liver|April 1, 1997
Histological improvement in patients with chronic hepatitis B virus infection treated with lamivudineP Honkoop, R A de Man, P E Zondervan, et al.
Journal of Hepatology|June 13, 1998
Efficacy of famciclovir treatment in chronic hepatitis B patients with different mutations at position 552 of the DNA polymerase geneL M Wolters, P Honkoop, H G Niesters, et al.
Drug Safety|July 1, 1997
Mitochondrial injury. Lessons from the fialuridine trialP Honkoop, H R Scholte, R A de Man, et al.
Lancet (London, England)|October 28, 1995
Hepatitis B reactivation after lamivudineP Honkoop, R A de Man, R A Heijtink, et al.
Pageof 55